uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
CureVac’s COVID-19 vaccine (CVnCoV)
Withdrawn from rolling review
Human
Details
EMA number
EMEA/H/C/005845
ATC code
J07BX03
Authorisation
-
Revision
-
EMA page
Therapeutic indication
COVID-19 Vaccine
Group:
Vaccines
Active substances
single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2
Marketing Authorisation Holder
CureVac AG
MAH
CureVac’s COVID-19 vaccine (CVnCoV) | uMedical